Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5700788 | European Journal of Surgical Oncology (EJSO) | 2017 | 30 Pages |
Abstract
The long-term US-FNAC results support this step-wise approach to melanoma patients. Patients with positive US-FNAC have a poor survival and can be spared a SNB. Patients with suspicious US and negative FNAC should undergo SNB to detect microscopic occult disease. Completely US-FNAC negative patients might only require follow-up and no SN staging at all.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
C.M.C. Oude Ophuis, C. Verhoef, D.J. Grünhagen, P. Siegel, A. Schoengen, J. Röwert-Huber, A.M.M. Eggermont, C.A. Voit, A.C.J. van Akkooi,